Rebalix
Vanguard · sheet of 5 September 2026
Vanguard · sheet of 5 September 2026ETF sheet · official issuer and register data
Vanguard USD Corporate Bond UCITS ETF (USD) Distributing
VUCP · IE00BZ163K21 · USD · domicile Ireland
Bonds · Corporate USD · Broad (all maturities) · North AmericaSFDR art. 6 (inferred)
Index tracked: Bloomberg Global Aggregate Corporate - United States Dollar Index
- TER
- 0.07%+ trans. 0.04%
- Fund size
- 3.9 bn EUR
- Tracking difference
- +0.00%3-year avg
- 🇮🇹 tax rate
- 25.97%white list 0.20%
- Replication
- Physical (sampled)
- Income
- Distributingmonthly
- Duration
- 6.20 yrsmedium (3–7 years)
Launch 24 Feb 2016 · costs from the KID as of 2 Sept 2026 · 8,648 securities held · 11 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the Bloomberg Global Aggregate Corporate – United States Dollar Index (the “Index”). The Fund invests in a representative sample of bonds included in the Index in order to closely match the Index's capital and income return. The Index measures the performance of a broad spread of US dollar denominated bonds paying a fixed rate of interest which are issued by companies. Bonds in the Index have…
Performance since series start (in euro) — base 100
31 Mar 2016 → 31 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +4.9% |
| 3 years | +10.3% |
| 5 years | +4.5% |
| 10 years | +23.5% |
| Since series start | +31.1% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 4.00% | 5.19% | 6.20% |
| Max drawdown | −5.15% | −5.98% | −24.40% |
| Sharpe | -1.34 | -0.57 | -1.06 |
| Sortino | -1.72 | -0.77 | -1.41 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VUCP · IE00BZ163K211
RebalixVUCP · IE00BZ163K21 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +7.75% | +7.88% | −0.13% |
| 2024 | +2.65% | +2.57% | +0.08% |
| 2023 | +8.53% | +8.47% | +0.06% |
| 2022 | −15.37% | −15.28% | −0.09% |
| 2020 | +9.68% | +9.68% | +0.00% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.9%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Distributions · per share, in USD
Frequency: monthly · last 12 months: 2.3843 USD (5.16% of NAV) · last ex-date 20 Aug 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 8 | 1.599 | — |
| 2025 | 12 | 2.4888 | +5.31% |
| 2024 | 12 | 2.3481 | +4.89% |
| 2023 | 12 | 2.0982 | +4.54% |
| 2022 | 12 | 1.6244 | +2.87% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 8,648 securities · top-10 weight = 3.2%
Countries (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
VUCP · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
— · Euronext Paris
+ 16 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BZ163K21
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BZ163K21
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · VUCP · IE00BZ163K212